Brett Hoffman

Brett Hoffman has a diverse work experience in the field of scientific research. Brett started their career as a Research Technician at the University of Alberta in 2007 and 2008. Brett then pursued their Ph.D. at the Vaccine and Infectious Disease Organization - International Vaccine Centre from 2008 to 2015. Following this, they worked as a Postdoctoral Associate at the University of Florida from 2016 to 2019, where they conducted research on viral non-coding RNA and its role in viral dissemination and pathogenesis. Brett is currently employed at Voyager Therapeutics, Inc. since 2019, where they have held several roles, including Senior Scientist II in Novel Capsid Discovery and Senior Scientist I in Novel Capsid Discovery/Vector Engineering. Their work involves vector engineering and the discovery of novel capsids. Overall, Brett Hoffman's work experience showcases their expertise in scientific research and their contributions to the field of molecular biology and virology.

Brett Hoffman earned a Bachelor of Science degree in Immunology and Infection from the University of Alberta, where they studied from 2003 to 2008. Brett then pursued further education at the University of Saskatchewan, completing their Doctor of Philosophy in Vaccinology and Immunotherapeutics from the School of Public Health between 2008 and 2015. In 2011, they also had a brief academic involvement at the Université de Montréal, although the specific degree and field of study there are unspecified.